Publications by authors named "Stan Altan"

Claim this Profile
P
Patient-Centric Drug Product Quality Specifications: a Convergence of Clinical and Nonclinical Considerations.
Stan Altan, Hans Coppenolle, Trine Kvist, Katharina Reckermann, Sandra Suarez-Sharp

AAPS J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissolution of Oral Solid Dosage Formulations: Surrogate Models and Real-time Release.
Melanie Dumarey, Tessa M Carducci, Matthew J Walworth, Casey J Smith, Salvador García-Muñoz, Stan Altan

AAPS J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixture Experimentation in Pharmaceutical Formulations: A Tutorial.
Lynne B Hare, Stan Altan, Hans Coppenolle

Pharm Stat· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quasi-Empirical Bayes methods for parameter estimation involving many small samples.
Kanaka Tatikola, Javier Cabrera, Chun Pang Lin, Helena Geys, Fetene Tekle, Stan Altan

J Biopharm Stat· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability analysis using mixed models: A critique of tolerance interval methods and a probabilistic solution.
Stan Altan, Paul Faya, Adam P Rauk, David LeBlond, John W Seaman

Pharm Stat· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bayesian Approach to Kinetic Modeling of Accelerated Stability Studies and Shelf Life Determination.
Joris Chau, Stan Altan, Anneleen Burggraeve, Hans Coppenolle, Yimer Wasihun Kifle

AAPS PharmSciTech· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DISSOLUTION PROFILE SIMILARITY ANALYSES-STATISTICAL PRINCIPLES, METHODS AND CONSIDERATIONS.
Thomas Hoffelder, David Leblond, Leslie Van Alstine, Dorys Argelia Diaz, Sandra Suarez-Sharp, Stan Altan

AAPS J· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissolution curve comparisons through the F(2) parameter, a Bayesian extension of the f(2) statistic.
Steven Novick, Yan Shen, Harry Yang, John Peterson, Dave LeBlond, Stan Altan

J Biopharm Stat· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letters to the editor.
Raymond Buck, Stan Altan

J Biopharm Stat· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Block designs in method transfer experiments.
Stan Altan, Jyh-Ming Shoung

J Biopharm Stat· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serially balanced designs for two sets of treatments.
Stan Altan

J Biopharm Stat· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double bootstrapping a tolerance limit.
Jyh-Ming Shoung, Stan Altan, Javier Cabrera

J Biopharm Stat· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A note on kinetic modeling of stability data and implications on pooling.
Stan Altan, Damaraju Raghavarao

J Biopharm Stat· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis